Though not everyone with IgA nephropathy deals with end-stage kidney disease, around 25% of them face this complication. But there may be another option: a clinical trial. Depending on what’s ...
This transcript has been edited for clarity. Matthew A. Sparks, MD: Hi. I'm Dr Matthew Sparks. Welcome to Medscape's InDiscussion series on chronic kidney disease (CKD). Today, we'll be discussing ...
Management assumes sustained revenue growth for the balance of the year, noting that some Q1 shipments will be recognized in ...
Hosted on MSN
What Are the Treatments for IgA Nephropathy?
IgA nephropathy is a progressive disease where immune proteins damage the kidneys' filtering units. Treatment options include medications and lifestyle changes to help slow progression and manage ...
IgA nephropathy (IgAN) is a kidney disorder caused by a buildup of immune complexes and the antibody called immunoglobulin A (IgA) inside the kidneys. This buildup causes inflammation in the kidneys.
Andrew S. Bomback, MD, MPH, comments on the impact of disparities in diagnosing and treating IgA nephropathy by nephrologists. Early detection and treatment of IgA nephropathy are critical for better ...
Hosted on MSN
Living well with IgA nephropathy
IgA nephropathy is a kidney condition in which immune proteins deposit in the kidney’s filters, causing inflammation that can progress slowly over years. While there is no cure, early diagnosis, ...
Proteinuria (protein in your urine) is a sign of kidney damage caused by IgA nephropathy. Treatment can help reduce proteinuria and preserve your kidney function longer. IgA nephropathy (IgAN) is a ...
GFR slope predicts kidney outcomes in IgA nephropathy beyond static measures. Learn how this could refine trials and risk ...
Between 20 and 50 percent of individuals with IgA nephropathy will experience kidney failure within two decades of diagnosis, though the timeline varies significantly from person to person. Regular ...
Travere Therapeutics (NASDAQ:TVTX) executives highlighted a first-quarter marked by an FDA approval, record demand for ...
MicroRNAs (miRNAs) might have important roles in the pathogenesis and progression of IgA nephropathy Abnormal expression of miR-148b in peripheral blood mononuclear cells might account for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results